Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 96 (RPL21P96)
- Target
- RPL21P96
- Molecular classification
- Other (pseudogene)
01
Overview
Ribosomal protein L21 pseudogene 96 (RPL21P96) is a processed pseudogene derived from the ribosomal protein L21 gene. Pseudogenes arise from duplication or retrotransposition events and typically lack the sequences necessary for transcription or translation into functional proteins. RPL21P96, like other ribosomal protein pseudogenes, does not code for a functional protein and does not participate in biological pathways, disease processes, or therapeutic mechanisms[1][3][8]. Its existence reflects evolutionary history rather than biological function.\n\nIf a functional or therapeutic gene is of interest, refer to ribosomal protein L21 (RPL21) rather than RPL21P96[5][7].
- Other names
- RPL21_41_1169RPL21P96
02
Mechanism of action
None
03
Biological functions
None (Does not encode a functional protein)
04
Disease associations
None known (No disease association for this pseudogene itself; note that mutations in the parental gene RPL21 are associated with Hypotrichosis simplex of the scalp, but not the pseudogene)
Beyond the preview
Go deeper on Ribosomal protein L21 pseudogene 96 (RPL21P96).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 96 (RPL21P96).